About
Clear Creek Bio is a private, clinical-stage biotech company focused on developing novel therapies to address cancer, infectious disease and pandemic preparedness. Our lead drug candidate, brequinar, is a dihydroorotate dehydrogenase (DHODH) inhibitor with oral bioavailability and high potency.
Cambridge